Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
CAS RN: 51333-22-3 | Product Number: B3909
Budesonide

Purity: >98.0%(HPLC)
- (+)-16α,17α-Butylidenedioxy-11β,21-dihydroxy-1,4-pregnadiene-3,20-dione
Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
---|---|---|---|---|---|
200MG |
$59.00
|
1 | 1 | 24 |
|
1G |
$200.00
|
2 | Contact Us | ≥40 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | B3909 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__2__5H__3__4O__6 = 430.54 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image), 200MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 51333-22-3 |
Reaxys Registry Number | 3633996 |
PubChem Substance ID | 160871371 |
Merck Index (14) | 1468 |
MDL Number | MFCD00083259 |
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 % (total of isomers) |
Elemental analysis(Carbon) | 68.00 to 71.00 % |
Specific rotation [a]20/D | +100 to +110 deg(C=0.28、CH2Cl2) |
Specific Rotation | 105° (C=0.28,CH2Cl2) |
Solubility in water | Insoluble |
Solubility (soluble in) | Chloroform, Methanol |
Solubility (slightly sol. in) | Acetone, Ethanol |
Pictogram |
![]() |
Signal Word | Warning |
Hazard Statements | H315 : Causes skin irritation. |
Precautionary Statements | P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves. P302 + P352 : IF ON SKIN: Wash with plenty of soap and water. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P362 : Take off contaminated clothing and wash before reuse. |
RTECS# | TU3723000 |
HS Number | 2937.29.9095 |
References
- 1)Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids(a review)
- 2)Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis(a review)
- 3)Budesonide: A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease(a review)
- 4)Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease(a review)
- 5)Treatment of inflammatory bowel disease: a review of medical therapy(a review)
- 6)Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis (a review)
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.